Education
About Us
Working with TipRanks
Follow Us
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
RESEARCH TOOLSreports
4886 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥1,825.00 - ¥2,720.00
Previous CloseN/A
Volume48.10K
Average Volume (3M)46.28K
Market Cap
¥60.01B
Enterprise ValueN/A
Total Cash (Recent Filing)¥10.17B
Total Debt (Recent Filing)¥7.42B
Price to Earnings (P/E)12.5
Beta0.60
Next Earnings
Aug 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield2.44%
Share Statistics
EPS (TTM)35.36
Shares Outstanding28,763,199
10 Day Avg. Volume47,970
30 Day Avg. Volume46,276
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)1.01
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ASKA Pharmaceutical Holdings Co., Ltd. News
PremiumCompany Announcements
ASKA Pharmaceutical Opposes Shareholder Proposal, Emphasizes Growth Strategy
PremiumCompany Announcements
ASKA Pharmaceutical Opposes Shareholder Proposal, Focuses on Growth Strategy
PremiumCompany Announcements
ASKA Pharmaceutical Reports Strong Sales and Positive Outlook for FY2025
PremiumCompany Announcements
ASKA Pharmaceutical Announces Increased Dividend Payout
PremiumCompany Announcements
ASKA Pharmaceutical Reports FY2024 Financial Results with Increased Dividends
PremiumCompany Announcements
ASKA Pharmaceutical Announces Leadership Changes to Drive Future Growth
PremiumCompany Announcements
ASKA Pharmaceutical Recognized for Dual-career and Co-parenting Support---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.57%
Mutual Funds
― Other Institutional Investors
93.90% Public Companies and
Individual Investors
4886 FAQ
What was ASKA Pharmaceutical Holdings Co., Ltd.’s price range in the past 12 months?
ASKA Pharmaceutical Holdings Co., Ltd. lowest stock price was ¥1825.00 and its highest was ¥2720.00 in the past 12 months.
What is ASKA Pharmaceutical Holdings Co., Ltd.’s market cap?
ASKA Pharmaceutical Holdings Co., Ltd.’s market cap is ¥60.01B.
When is ASKA Pharmaceutical Holdings Co., Ltd.’s upcoming earnings report date?
ASKA Pharmaceutical Holdings Co., Ltd.’s upcoming earnings report date is Aug 11, 2025 which is in 86 days.
How were ASKA Pharmaceutical Holdings Co., Ltd.’s earnings last quarter?
ASKA Pharmaceutical Holdings Co., Ltd. released its earnings results on May 12, 2025. The company reported ¥35.36 earnings per share for the quarter, beating the consensus estimate of N/A by ¥35.36.
Is ASKA Pharmaceutical Holdings Co., Ltd. overvalued?
According to Wall Street analysts ASKA Pharmaceutical Holdings Co., Ltd.’s price is currently Overvalued.
Does ASKA Pharmaceutical Holdings Co., Ltd. pay dividends?
ASKA Pharmaceutical Holdings Co., Ltd. pays a Annually dividend of ¥50 which represents an annual dividend yield of 2.44%. See more information on ASKA Pharmaceutical Holdings Co., Ltd. dividends here
What is ASKA Pharmaceutical Holdings Co., Ltd.’s EPS estimate?
ASKA Pharmaceutical Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ASKA Pharmaceutical Holdings Co., Ltd. have?
ASKA Pharmaceutical Holdings Co., Ltd. has 28,763,199 shares outstanding.
What happened to ASKA Pharmaceutical Holdings Co., Ltd.’s price movement after its last earnings report?
ASKA Pharmaceutical Holdings Co., Ltd. reported an EPS of ¥35.36 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.43%.
Which hedge fund is a major shareholder of ASKA Pharmaceutical Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4886
---
Company Description
ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
---
Technical Analysis
Terumo
―
Chugai Pharmaceutical Co
―
Sumitomo Dainippon Pharma Co
―
Eisai Co
―
Takeda Pharmaceutical Co
―
---